Literature DB >> 22266325

N-arachidonoyl glycine induces macrophage apoptosis via GPR18.

Rina Takenouchi1, Kazuhiko Inoue, Yuki Kambe, Atsuro Miyata.   

Abstract

N-arachidonoyl glycine (NAGly), a member of lipoamino acids, was reported to exhibit anti-inflammatory effects in experimental ear edema or peritonitis. However the underlying mechanisms have not been clarified so far. In this study, we attempt to investigate the effects of NAGly on macrophages, including the relevant signaling pathways. NAGly potently induced apoptosis in mouse macrophage-derived cell line, RAW264.7. Pretreatment with inhibitors for MEK and p38 MAPK prevented the apoptosis induced by NAGly, although NAGly activated ERK1/2, p38 MAPK and JNK. Further, we focused on implication of GPR18, one of the orphan G protein-coupled receptors, because NAGly has been reported as a candidate ligand for GPR18. Pretreatment with pertussis toxin or siRNA to knock down the expression of GPR18 significantly attenuated the apoptosis induced by NAGly. In mouse peritoneal macrophages, the expression of GPR18 mRNA was elevated in proinflammatory stimulated macrophages but not in anti-inflammatory stimulated macrophages; consistently, NAGly remarkably reduced cell viability of the former, as compared to the latter. These results suggest that NAGly might be involved in function of macrophages through GPR18.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266325     DOI: 10.1016/j.bbrc.2012.01.027

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  GPR18 in microglia: implications for the CNS and endocannabinoid system signalling.

Authors:  D McHugh
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

2.  Activation of GPR18 by cannabinoid compounds: a tale of biased agonism.

Authors:  Linda Console-Bram; Eugen Brailoiu; Gabriela Cristina Brailoiu; Haleli Sharir; Mary E Abood
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

Review 3.  Endocannabinoid signaling pathways: beyond CB1R and CB2R.

Authors:  Roger Gregory Biringer
Journal:  J Cell Commun Signal       Date:  2021-05-12       Impact factor: 5.782

Review 4.  Cannabinoid receptors: nomenclature and pharmacological principles.

Authors:  Linda Console-Bram; Jahan Marcu; Mary E Abood
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-02-28       Impact factor: 5.067

Review 5.  Endothelial atypical cannabinoid receptor: do we have enough evidence?

Authors:  Alexander I Bondarenko
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

6.  Asymmetric synthesis of novel N-(1-phenyl-2,3-dihydroxypropyl)arachidonylamides and evaluation of their anti-inflammatory activity.

Authors:  Padmanabha V Kattamuri; Rebecca Salmonsen; Catherine McQuain; Sumner Burstein; Hao Sun; Guigen Li
Journal:  Life Sci       Date:  2012-07-20       Impact factor: 5.037

7.  Top-down lipidomics of low density lipoprotein reveal altered lipid profiles in advanced chronic kidney disease.

Authors:  Ana Reis; Alisa Rudnitskaya; Pajaree Chariyavilaskul; Neeraj Dhaun; Vanessa Melville; Jane Goddard; David J Webb; Andrew R Pitt; Corinne M Spickett
Journal:  J Lipid Res       Date:  2014-11-25       Impact factor: 5.922

8.  N-Arachidonyl glycine does not activate G protein-coupled receptor 18 signaling via canonical pathways.

Authors:  Van B Lu; Henry L Puhl; Stephen R Ikeda
Journal:  Mol Pharmacol       Date:  2012-10-25       Impact factor: 4.436

9.  GPR18 Controls Reconstitution of Mouse Small Intestine Intraepithelial Lymphocytes following Bone Marrow Transplantation.

Authors:  Amy M Becker; Derrick J Callahan; Justin M Richner; Jaebok Choi; John F DiPersio; Michael S Diamond; Deepta Bhattacharya
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

10.  N-Arachidonoyl glycine suppresses Na⁺/Ca²⁺ exchanger-mediated Ca²⁺ entry into endothelial cells and activates BK(Ca) channels independently of GPCRs.

Authors:  Alexander I Bondarenko; Konstantin Drachuk; Olga Panasiuk; Vadim Sagach; Andras T Deak; Roland Malli; Wolfgang F Graier
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.